Cleveland Clinic is part of the largest scleroderma trial ever undertaken to evaluate the efficacy and safety of oral nintedanib treatment in systemic sclerosis associated interstitial lung disease.
The combination of robot-assisted SEEG with laser ablation is still novel and evolving. This case study illustrates the advantages of this minimally invasive approach in a 17-year-old with intractable seizures.
Interim results from a major study of a leadless pacemaker show good safety and efficacy, echoing a recent trial of a similar device. Here’s how these devices may shape the future of cardiac pacing.
New Cleveland Clinic research shows that serial hepatic USG — paired with confirmatory CT/MRI scans when needed — has high sensitivity and specificity for detecting asymptomatic uveal melanoma metastases.
Cleveland Clinic researchers demonstrate cell-specific responses to extracellular viruses, which may be helpful in uncovering the mechanisms behind determining a cell’s fate.
Understand how social media and other digital communications deliver measurable results in making patients healthy and how it helps health systems deliver on goals that relate directly to their successes.
Cleveland Clinic researchers find overly stringent eligibility criteria relevant to expected and observed adverse events may exclude specific patient populations from randomized clinical trials of hematologic malignancies.
This case of a young woman found to have lupus nephritis and antiphospholipid syndrome shows how renal biopsy can establish the pattern of injury and guide immunosuppressive therapy.
T-scores are necessary to establish the diagnosis of osteoporosis and to estimate disease prevalence, but they should not be used as the sole determinant to make treatment decisions in an individual.
A new analysis of 1,241 patients undergoing ablation for persistent afib reveals for the first time just how important the diagnosis-to-ablation time interval can be. A study author discusses the findings.